Glasgow, UK – Monday 11th September 2023: Glasgow diagnostics spinout Microplate Dx has closed a £2.5M seed funding round to develop its point-of-care diagnostic platform which can confirm the presence of bacteria and guide a Read More
Tags :University of Strathclyde
Dxcover – a Glasgow-based company developing a blood test that can detect cancer at an early stage – has raised £9.7m through a Series A investment round and grant funding. The £7.5m funding round was Read More
Scottish cyber start-up Lupovis secures over £615,000 in pre-seed funding Above average pre-seed investment signals high interest in the Lupovis platform and a successful future for Scotland’s newest cyber-spin out GLASGOW, UK – Lupovis, a University Read More
Cancer diagnostics firm completes £3.5M funding round Thursday 4th March 2021 ClinSpec Diagnostics Limited (ClinSpec Dx), the Glasgow-based developer of liquid biopsies for early detection of cancer, has reached its round two funding target Read More
Early cancer detection technology secures £2.4M funding boost Efforts to improve the early detection of cancer have received a significant boost with a £2.4 million funding deal to support the further development of innovative testing technology. Read More
Synaptec’s innovative technology can reduce downtime and allow easier and cheaper monitoring of the increasingly complex electric power grid The Foresight Williams Technology EIS Fund invested £2 million alongside £100,000 from the newly created Foresight Scottish Read More